Corporate Profile
iRhythm is a digital healthcare company redefining the way cardiac arrhythmias are clinically diagnosed by combining our wearable biosensing technology with cloud-based data analytics and machine- learning capabilities. Our goal is to be the leading provider of first-line ambulatory electrocardiogram, or ECG, monitoring for patients at risk for arrhythmias.

We have created a unique platform, ZIO by iRhythm, which we believe allows physicians to diagnose many arrhythmias more quickly and efficiently than traditional technologies, avoiding multiple indeterminate tests, allowing for appropriate medical intervention and potentially avoiding more serious downstream medical events, including stroke.
IRTC (Common Stock)
ExchangeNASDAQ (US Dollar)
Change (%) Stock is Up 0.02 (0.06%)
Data as of 04/28/17 1:30 p.m. ET
Refresh quote
Data provided by Nasdaq. Minimum 15 minutes delayed.
Stock chart for: IRTC.O.  Currently trading at $35.26 with a 52 week high of $40.48 and a 52 week low of $22.16.
Recent News
04/19/17iRhythm Technologies to Report First Quarter 2017 Financial Results on May 3, 2017Printer Friendly Version
04/10/17Zio by iRhythm Gains Further Recognition as Key Diagnostic Cardiac Monitoring System by US and UK Health OrganizationsPrinter Friendly Version
02/15/17iRhythm Technologies Announces Fourth Quarter and 2016 Financial Results and Provides Full Year 2017 Financial OutlookPrinter Friendly Version
Upcoming Events
05/03/17 4:30 p.m. ET
iRhythm Technologies Inc Q1 2017 Earnings Conference Call